Evidence Hub

Houttuynia Drip Improves Clinical Outcome in Elderly Patients with Refractory Pneumonia on Routine Treatment and Nursing Care

Qian Dong, Longmei Yu, Shou-Wei Wang, Shengxun Lin

Current Topics in Nutraceutical Research, 2023

104 participants

Abstract

We have analyzed the effect of Houttuynia administration on the distribution of the types of bacteria and their antimicrobial susceptibility in the bronchoalveolar lavage fluid of elderly patients with refractory pneumonia. To this end, patients with refractory pneumonia were divided into two groups: the control group receiving conventional treatment and the experimental group receiving Houttuynia along with conventional treatment. There were no pathogenic bacteria detected in 56/104 patients, with 48/104 patients showing the presence of Gram-negative bacteria, Klebsiella pneumoniae, followed by Gram-positive Streptococcus pneumoniae and Staphylococcus aureus. Streptococcus pneumoniae was sensitive to ertapenem, vancomycin, chloramphenicol, ofloxacin, and levofloxacin; Staphylococcus aureus was sensitive to vancomycin, ofloxacin, and levofloxacin; and Klebsiella pneumoniae was sensitive to ofloxacin and levofloxacin. Gram-negative bacteria sensitive to antibiotics such as ofloxacin and levofloxacin were the main pathogens in the bronchoalveolar lavage fluid of refractory pneumonia patients. There was a significant (<0.05) increase in clinical efficacy of the conventional treatment from 76.9% to 92.3% following Houttuynia administration.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free